Nonphospholipid Vesicles of Carboplatin for Lung Targeting

Drug Delivery - United Kingdom
doi 10.1080/713840364
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Docosahexaenoic Acid Monoglyceride Increases Carboplatin Activity in Lung Cancer Models by Targeting EGFR

Anticancer Research
MedicineCancer ResearchOncology
2017English

Targeting of Peptidergic Vesicles in Cotransmitting Terminals

Journal of Neuroscience
Neuroscience
2001English

P2.12-09 Efficacy and Safety of Carboplatin and Paclitaxel for Patients Preexisting Interstitial Lung Disease With Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

MARCKS Regulates Membrane Targeting of Rab10 Vesicles to Promote Axon Development

Cell Research
Cell BiologyMolecular Biology
2014English

Analysis of Continuous First‑line Treatment With Docetaxel and Carboplatin for Advanced Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2014English

Targeting the Lung: Challenges in Gene Therapy for Cystic Fibrosis

2013English

Targeting Pathways Downstream of KRAS in Lung Adenocarcinoma

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2014English

Pharmacokinetics of Carboplatin and Etoposide in a Hemodialysis Patient With Small Cell Lung Carcinoma.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy